1Sri Wahyuni Ernaningsih, 2Prasetyowati Subchan, 3Agung Putra
1Postgraduate student of the Department of Biomedical Sciences in Medical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
2Department of Biomedical Sciences Postgraduate Medical Science, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
3Department of Anatomical Pathology, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
DOI : https://doi.org/10.47191/ijmra/v7-i04-39Google Scholar Download Pdf
ABSTRACT:
Psoriasis is known as a complex disease with interactions between genes, the body's immune system and environmental factors, which is a chronic inflammation characterized by scaly red plaques. Secretome Hypoxic Mesenchymal Stem Cells (S-HypMSCs) contain various components released by MSCs consisting of chemokines, growth factors and anti-inflammatory cytokines, making it possible as a therapeutic option. This study aims to investigate the effect of S-HypMSCs on psoriasis improvement. MSCs were isolated from the umbilical cord of rats, Secretome which could be mixed with cream and applied to the wounds of psoriasis-like animal models at a dose of 100 μL/kgBW in 100 mg cream for group P1 and 200 μL/kgBW in 100 mg cream for group P2. The control group was treated with a cream base. The mRNA expression of AP1S3 was analyzed using quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). All examinations were assessed on day 14. There was a significant difference in the healthy group against the psoriasis-like group, psoriasis-like treatment 1 and treatment 2 groups. administration of S-HypMSCs at a dose of 100 μL/kgBW in 100 mg cream and a dose of 200 μL/kgBW in 100 mg cream significantly decreased AP1S3 expression in Psoriasis-like male white rats of the Wistar strain. The administration of S-HypMSCs cream at a dose of 100 μL/kgBW in 100 mg cream and a dose of 200 μL/kgBW in 100 mg cream had an effect on decreasing AP1S3 gene expression between treatment groups compared to controls in psoriasis-like male Wistar rats. imiquimod induced.
KEYWORDS:psoriasis, MSCs, Secretome, AP1S3, IL36
REFERENCES1) Capon F. The genetic basis of psoriasis. International Journal of Molecular Sciences. 2017;18(12):1-9. doi:10.3390/ijms18122526
2) Roszkiewicz M, Dopytalska K, Szymańska E, Jakimiuk A, Walecka I. Environmental risk factors and epigenetic alternations in psoriasis. Annals of Agricultural and Environmental Medicine. 2020;27(3):335-342. doi:10.26444/aaem/112107
3) Samotij D, Szczęch J, Reich A. Generalized pustular psoriasis: Divergence of innate and adaptive immunity. International Journal of Molecular Sciences. 2021;22(16). doi:10.3390/ijms22169048
4) Park SR, Kim JW, Jun HS, Roh JY, Lee HY, Hong IS. Stem Cell Secretome and Its Effect on Cellular Mechanisms Relevant to Wound Healing. Molecular Therapy. 2018;26(2):606-617. doi:10.1016/j.ymthe.2017.09.023
5) Nair A, Jacob S, Al-Dhubiab B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Brazilian Journal of Pharmaceutical Sciences. 2013;49(3):423-434. doi:10.1590/S1984-82502013000300004
6) Smajlović A, Haverić A, Alić A, et al. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Molecular Biology Reports. 2021;48(5):4295-4303. doi:10.1007/s11033-021-06445-3
7) Gao F, Chiu SM, Motan DAL, et al. Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death and Disease. 2016;7(1). doi:10.1038/cddis.2015.327
8) De Jesús-Gil C, Ruiz-Romeu E, Ferran M, et al. CLA+ T cell response to microbes in psoriasis. Frontiers in Immunology. 2018;9(JUN). doi:10.3389/fimmu.2018.01488
9) Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clinical Science. 2013;124(3):165-176. doi:10.1042/CS20120226
10) Schottelius AJG, Mayo MW, Balfour Sartor R, Baldwin AS. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. Journal of Biological Chemistry. 1999;274(45):31868-31874. doi:10.1074/jbc.274.45.31868
11) Simões IN, Boura JS, Dos Santos F, et al. Human mesenchymal stem cells from the umbilical cord matrix: Successful isolation and ex vivo expansion using serum-/xeno-free culture media. Biotechnology Journal. 2013;8(4):448-458. doi:10.1002/biot.201200340
12) Rezaie J, Heidarzadeh M, Hassanpour M, et al. The Angiogenic Paracrine Potential of Mesenchymal Stem Cells. Update on Mesenchymal and Induced Pluripotent Stem Cells. Published online 2020. doi:10.5772/intechopen.84433
13) Műzes G, Sipos F. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases. Cells. 2022;11(15). doi:10.3390/cells11152300
14) Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. The BMJ. 2020;369(May). doi:10.1136/bmj.m1590
15) Lin H, Chen H, Zhao X, et al. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration. Journal of Translational Medicine. 2021;19(1):1-13. doi:10.1186/s12967-021-03125-5
16) Amato M, Santonocito S, Viglianisi G, Tatullo M, Isola G. Impact of Oral Mesenchymal Stem Cells Applications as a Promising Therapeutic Target in the Therapy of Periodontal Disease. International Journal of Molecular Sciences. 2022;23(21). doi:10.3390/ijms232113419
17) Bahir B, S. Choudhery M, Hussain I. Hypoxic Preconditioning as a Strategy to Maintain the Regenerative Potential of Mesenchymal Stem Cells. Regenerative Medicine. Published online 2020:1-15. doi:10.5772/intechopen.93217
18) Salman S, Attar YA El, Salem ML, Kashef SM, Zidan AAA, Abdel-Latif AM. WITHDRAWN: The effect of anti IL-2/IL-2 complex versus stand-alone low dose of IL-2 on imiquimod induced psoriasis like skin inflammation model. Immunology Letters. 2020;(September). doi:10.1016/j.imlet.2020.09.003
Volume 07 Issue 04 April 2024
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 11 (November 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 November 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.